Key result
Pharmacological activation of cannabinoid receptor 2 with AM1241 significantly reduced the susceptibility to atrial fibrillation in Angiotensin II-infused mice.
Why the study?
Although activating CB2R has a protective effect on the myocardium, the role of CB2R in AF remains unknown.
Does AM1241 reduce AF inducibility and oxidative stress in Angiotensin II-infused mice?
Does AM1241 reduce AF inducibility and oxidative stress in Angiotensin II-infused mice?
Pharmacological activation of CB2R with AM1241 protects against Angiotensin II-induced atrial fibrillation and oxidative stress in a mouse model.
Supports CB2R activation in this Ang II model; leaves open translation to human AF prevention.
Background Atrial fibrillation (AF) is the most frequent arrythmia managed in clinical practice. Several mechanisms have been proposed to contribute to the occurrence and persistence of AF, in which oxidative stress plays a non-negligible role. The endocannabinoid system (ECS) is involved in a variety physiological and pathological processes. Cannabinoid receptor 1 (CB1R) and cannabinoid receptor 2 (CB2R) are expressed in the heart, and studies have shown that activating CB2R has a protective effect on the myocardium. However, the role of CB2R in AF is unknown. Materials and methods Angiotensin II (Ang II)-infused mice were treated with the CB2R agonist AM1241 intraperitoneally for 21 days. Atrial structural remodeling, AF inducibility, electrical transmission, oxidative stress and fibrosis were measured in mice. Results The susceptibility to AF and the level of oxidative stress were increased significantly in Ang II-infused mice. In addition, nicotinamide adenine dinucleotide phosphate oxidase 2 (NOX2), NOX4, and oxidized Ca2+/calmodulin-dependent protein kinase II (ox-CaMKII) were highly expressed. More importantly, treatment with AM1241 activated CB2R, resulting in a protective effect. Conclusion The present study demonstrates that pharmacological activation of CB2R exerts a protective effect against AF via a potential NOX/CaMKII mechanism. CB2R is a potential therapeutic target for AF.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2022) studied Atrial fibrillation (n=75). AM1241 vs. Vehicle was evaluated on Atrial fibrillation inducibility (p=<0.05). Pharmacological activation of cannabinoid receptor 2 with AM1241 significantly reduced the susceptibility to atrial fibrillation in Angiotensin II-infused mice.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: